Skip to main content
. 2017 Nov 13;14(1):37–46. doi: 10.1007/s11302-017-9590-3

Fig. 3.

Fig. 3

NTPDase2 expression extends into scar tissue in fibrosis but is still predominant on portal fibroblasts. a Co-immunostaining of healthy wild-type liver tissue of NTPDase2 (red) with Thy-1 (green), a marker of portal fibroblasts. b After 6 weeks of CCl4 treatment. c Co-immunostaining of healthy wild-type liver tissue of NTPDase2 (red) with A6 (green), a marker of bile duct epithelia and hepatic progenitor cells. d After 6 weeks of CCl4 treatment